Visualization of transient encounter complexes in protein-protein association

Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0520, USA.
Nature (Impact Factor: 41.46). 12/2006; 444(7117):383-6. DOI: 10.1038/nature05201
Source: PubMed


Kinetic data on a number of protein-protein associations have provided evidence for the initial formation of a pre-equilibrium encounter complex that subsequently relaxes to the final stereospecific complex. Site-directed mutagenesis and brownian dynamics simulations have suggested that the rate of association can be modulated by perturbations in charge distribution outside the direct interaction surfaces. Furthermore, rate enhancement through non-specific binding may occur by either a reduction in dimensionality or the presence of a short-range, non-specific attractive potential. Here, using paramagnetic relaxation enhancement, we directly demonstrate the existence and visualize the distribution of an ensemble of transient, non-specific encounter complexes under equilibrium conditions for a relatively weak protein-protein complex between the amino-terminal domain of enzyme I and the phosphocarrier protein HPr. Neither the stereospecific complex alone nor any single alternative conformation can account fully for the intermolecular paramagnetic relaxation enhancement data. Restrained rigid-body simulated annealing refinement against the paramagnetic relaxation enhancement data enables us to obtain an atomic probability distribution map of the non-specific encounter complex ensemble that qualitatively correlates with the electrostatic surface potentials on the interacting proteins. Qualitatively similar results are presented for two other protein-protein complexes.

Download full-text


Available from: Chun Tang
  • Source
    • "The strategy that we have used for this purpose relies on the ability to extract from time and spatially averaged data the contributions to the experimental observables that come from the lowpopulation states present as a result of conformational fluctuations. Intermediate states determined in this way have been already described using paramagnetic resonance enhancement (PRE) (Tang et al., 2006) and RDC (De Simone et al., 2013a; De Simone et al., 2013b) measurements, complementing approaches in which NMR parameters specific for these states are obtained directly, in particular by relaxation–dispersion methods (Korzhnev et al., 2004, 2010; Bouvignies et al., 2011; Neudecker et al., 2012). By applying this approach using RDCs to human lysozyme, we generated a structural ensemble representing the free state of this enzyme that reveals large breathing motions between the α and β domains (Figure 1A and Figure 1—figure supplements 1,2). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Enzymes can increase the rate of biomolecular reactions by several orders of magnitude. Although the steps of substrate capture and product release are essential in the enzymatic process, complete atomic-level descriptions of these steps are difficult to obtain because of the transient nature of the intermediate conformations, which makes them largely inaccessible to standard structure determination methods. We describe here the determination of the structure of a low-population intermediate in the product release process by human lysozyme through a combination of NMR spectroscopy and molecular dynamics simulations. We validate this structure by rationally designing two mutations, the first engineered to destabilise the intermediate and the second to stabilize it, thus slowing down or speeding up, respectively, product release. These results illustrate how product release by an enzyme can be facilitated by the presence of a metastable intermediate with transient weak interactions between the enzyme and the product.
    Full-text · Article · Jan 2015 · eLife Sciences
  • Source
    • "The PRE depends on the distance between a paramagnet and adjacent nuclei and can provide long-distance ($30 A ˚ ) information quantified by the H N -G 2 PRE rate (Supplemental Experimental Procedures) for each amide proton (Clore and Iwahara, 2009). The PRE approach is ideally suited to the analysis of weak intermolecular associations (Clore and Iwahara, 2009), providing distance information that can be used to visualize transient and lowly populated (<0.5%) protein states (Tang et al., 2006, 2008) such as those occurring in the early stages of amyloid formation. To enable these experiments, variants containing a solventexposed cysteine were created in DN6 by mutating either S20 (AB loop), S33 (BC loop), or S61 (DE loop) to cysteine (Figure 1A) while maintaining the disulfide bond involving C25 and C80 (Experimental Procedures). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the early stages of amyloid formation, heterogeneous populations of oligomeric species are generated, the affinity, specificity, and nature of which may promote, inhibit, or define the course of assembly. Despite the importance of the intermolecular interactions that initiate amyloid assembly, our understanding of these events remains poor. Here, using amyloidogenic and nonamyloidogenic variants of β2-microglobulin, we identify the interactions that inhibit or promote fibril formation in atomic detail. The results reveal that different outcomes of assembly result from biomolecular interactions involving similar surfaces. Specifically, inhibition occurs via rigid body docking of monomers in a head-to-head orientation to form kinetically trapped dimers. By contrast, the promotion of fibrillation involves relatively weak protein association in a similar orientation, which results in conformational changes in the initially nonfibrillogenic partner. The results highlight the complexity of interactions early in amyloid assembly and reveal atomic-level information about species barriers in amyloid formation.
    Full-text · Article · Jun 2014 · Molecular Cell
  • Source
    • "Proteomic approaches combined with bioinformatics method can reconstruct regulatory networks, signaling cascades, and metabolic pathways upon drug treatment (Wong et al., 2008). It has played an important role in significantly accelerating stages of drug discovery and development such as target discovery or mechanism of drug action (Tang et al., 2006; Wang et al., 2012b). Identification of the putative targets of natural products is an important aspect of current drug discovery and will aid drug development (Gersch et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Scoparone is an active ingredient of Yinchenhao (Artemisia annua L.), a well-known Chinese medicinal plant, and has been utilized in prevention and therapy of liver damage. However, the molecular drug targets associated with the pharmacological effects of scoparone are largely unknown. In the present article, we extend the previous research on Yinchenhao through a study of its active ingredient and thus the putative targets of scoparone. We employed two-dimensional gel electrophoresis, and all proteins expressed were identified by MALDI-TOF/TOF MS and database research. Protein-interacting networks and pathways were also mapped and evaluated. The possible protein network associated with scoparone was constructed, and contribution of these proteins to the protective effect of scoparone against the carbon tetrachloride-induced acute liver injury in rats are discussed herein. Hepatoprotective effects of scoparone on liver injury in rats were associated with regulated expression of six proteins which were closely related in our protein-protein interaction network, and appear to be involved in antioxidation and signal transduction, energy production, immunity, metabolism, and chaperoning. These observations collectively provide new insights on the molecular mechanisms of scoparone action against hepatic damage in rats.
    Full-text · Article · Mar 2013 · Omics: a journal of integrative biology
Show more